Evidence map›Paper›PMID 33607075›Full record

ReviewExperimental eye research2021

The cornea IV immunology, infection, neovascularization, and surgery chapter 1: Corneal immunology.

Hazem M Mousa, Daniel R Saban, Victor L Perez

Abstract readReview
In one paragraph

Review in Experimental eye research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Enhanced immune responses to vaccine antigens in the corneal stroma.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  17. Review
  18. Immune responses to injury and their links to eye disease.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  19. Immune cells in lens injury repair and fibrosis.Experimental eye research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hazem M MousaFoster Center for Ocular Immunology at Duke Eye Center, Duke University Medical Center, Durham, NC, USA.
Daniel R SabanFoster Center for Ocular Immunology at Duke Eye Center, Duke University Medical Center, Durham, NC, USA; Department of Immunology, Duke University School of Medicine, Durham, NC, USA.
Victor L PerezFoster Center for Ocular Immunology at Duke Eye Center, Duke University Medical Center, Durham, NC, USA. Electronic address: victor.perez.quinones@duke.edu.

Funding

Defining the Immune Cell Roles in Meibomian Gland Dysfunction in the Context of Ocular Surface Immune DiseasesR01EY021798 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI SABAN, DANIEL RAPHAEL · 2012 to 2025
$5.3M
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor DegenerationR01EY030906 · NEI · DUKE UNIVERSITY · PI Daniel Raphael Saban · 2020 to 2026
$3.5M
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplantsR01EY030283 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Robert Benjamin Levy, Victor L Perez · 2020 to 2026
$3.1M
Small Molecule Anti-Inflammatories for Ocular Graft Versus Host DiseaseR41EY029185 · NEI · EYEDESIS BIOSCIENCES, LLC · PI PEREZ, VICTOR L · 2018 to 2018
$219k
NEI NIH HHS R01 EY021798NEI NIH HHS R01 EY030283NEI NIH HHS R01 EY030906NEI NIH HHS R41 EY029185
6 · The paper itself

Abstract

purposeof Review: This review offers an informed and up-to-date insight on the immune profile of the cornea and the factors that govern the regulation of such a unique immune environment. SUMMARY: The cornea is a unique tissue that performs the specialized task of allowing light to penetrate for visual interpretation. To accomplish this, the ocular surface requires a distinct immune environment that is achieved through unique structural, cellular and molecular factors. Not only must the cornea be able to fend off invasive infectious agents but also control the inflammatory response as to avoid collateral, and potentially blinding damage; particularly of post-mitotic cells such as the corneal endothelium. To combat infections, both innate and adaptive arms of the inflammatory immune response are at play in the cornea. Dendritic cells play a critical role in coordinating both these responses in order to fend off infections. On the other side of the spectrum, the ocular surface is also endowed with a variety of anatomic and physiologic components that aid in regulating the immune response to prevent excessive, potentially damaging, inflammation. This attenuation of the immune response is termed immune privilege. The balance between pro and anti-inflammatory reactions is key for preservation of the functional integrity of the cornea. RECENT

findingsThe understanding of the molecular and cellular factors governing corneal immunology and its response to antigens is a growing field. Dendritic cells in the normal cornea play a crucial role in combating infections and coordinating the inflammatory arms of the immune response, particularly through coordination with T-helper cells. The role of neuropeptides is recently becoming more highlighted with different factors working on both sides of the inflammatory balance.

Indexed as

Adaptive ImmunityAnimalsCorneaCorneal DiseasesCorneal NeovascularizationEye InfectionsHumansImmunity, InnateCorneaImmune regulationImmunologyOcular immunology

Identifiers

PMID33607075
PMCPMC8462940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.